The quantification of NKp44+ cells in the tumor infiltrate of CRC patients could be of great interest, as it has been shown that CRC-initiating cells preferentially express ligands for NKp30 and NKp44 (93, 167). This evidence concerns the gene NCR2 and neoplasm.